
Kyrazone S 1000mg/500mg Injection
Marketer
Kyna Pharmaceuticals
Salt Composition
Cefoperazone (1000mg) + Sulbactam (500mg)
Overview Kyrazone S 1000mg/500mg Injection
Combiflox, a 1000mg/500mg injectable dual-action antibiotic, combats diverse bacterial infections by inhibiting microbial proliferation and halting infection spread. Administration must be strictly under a physician's guidance; complete the prescribed regimen, even with symptom improvement, as premature cessation may reduce efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Report worsening symptoms or allergic reactions (rash, itching, swelling, dyspnea) immediately. Inform your doctor of all current medications, especially if pregnant or breastfeeding. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing, avoid driving if experiencing drowsiness or dizziness. Adequate rest, a nutritious diet, and sufficient hydration will aid recovery. Your physician may order blood tests and other diagnostic procedures to monitor treatment response.
Uses of Kyrazone S 1000mg/500mg Injection
Combating Bacterial Infections
Major Benefits of Kyrazone S 1000mg/500mg Injection:
Administering this medication requires a healthcare professional; self-medication is strictly prohibited.
Common Side effects of Kyrazone S 1000mg/500mg Injection:
- Decreased white blood cell count (neutrophils)
- Decreased white blood cell count (lymphocytes)
- Decreased hemoglobin
- Decreased hematocrit level
- Low blood platelets
- Coagulation disorder
- Increased white blood cell count (eosinophils)
- Diarrhea
- Nausea
- Increased alanine aminotransferase
- Increased aspartate aminotransferase
- Increased alkaline phosphatase level in blood
- Vomiting
- Increased bilirubin in the blood
How to use Kyrazone S 1000mg/500mg Injection:
Administering this medication will be handled by your healthcare provider; self-medication is strictly prohibited.
How Kyrazone S 1000mg/500mg Injection works:
Kyrazone S Injection (1000mg/500mg) unites Cefoperazone, a crucial antibiotic, with Sulbactam, a beta-lactamase inhibitor. Cefoperazone's mechanism involves disrupting bacterial cell wall synthesis, vital for bacterial viability. Sulbactam's role is to counteract bacterial resistance mechanisms, thereby optimizing Cefoperazone's antibacterial effect.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Kyrazone S 1000mg/500mg Injection and alcohol can lead to adverse effects including facial redness, rapid pulse, vomiting, dehydration, chest discomfort, and hypotension (a disulfiram-like reaction).
PregnancySAFE IF PRESCRIBED
The injectable medication Kyrazone S (1000mg/500mg) is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or absent negative impacts on fetal development; nevertheless, clinical data from human trials remain scarce.
Breast feedingSAFE IF PRESCRIBED
Kyrazone S 1000mg/500mg Injection poses no known breastfeeding risk. Research in humans indicates minimal to negligible drug transfer into breast milk, presenting no apparent danger to the infant.
DrivingCONSULT YOUR DOCTOR
Kyrazone S 1000mg/500mg Injection's impact on driving ability is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Kyrazone S 1000mg/500mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding Kyrazone S 1000mg/500mg Injection's use in individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Kyrazone S 1000mg/500mg Injection :
Omit a Kyrazone S 1000mg/500mg Injection dose? Seek your physician's advice.
Facts to Know About Kyrazone S 1000mg/500mg Injection
| Label | Value |
|---|---|
| Developing Good Habits | No. |
| Type of Therapy | Antimicrobials |
